Rare diseases
Investigational molecules
Locations
Back to Spain60 clinical trials in Castilleja De La Cuesta, Spain. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in SpainEnsayosClinicos.es(opens in a new tab)Study Comparing ABP 692 and Ocrelizumab for Patients with Relapsing-Remitting Multiple Sclerosis
SpainStudy on Long-Term Safety and Effectiveness of Ofatumumab for Patients with Relapsing Multiple Sclerosis
SpainStudy on the Safety and Efficacy of MK-0616 for Adults with High Cholesterol
SpainStudy on the Safety and Effectiveness of Melatonin and Ocrelizumab for Patients with Primary Progressive Multiple Sclerosis
SpainStudy on the Effects of AZD5004 and Semaglutide for Adults with Type 2 Diabetes
SpainStudy on the Effectiveness and Safety of Finerenone and Empagliflozin in Adults with Chronic Kidney Disease and Type 2 Diabetes
SpainStudy on the Effectiveness of Enlicitide Chloride in Reducing Cardiovascular Events in Patients with Atherosclerotic Cardiovascular Disease
SpainStudy on the Effectiveness and Safety of Remibrutinib Compared to Teriflunomide for Patients with Relapsing Multiple Sclerosis
SpainStudy on the Effectiveness and Safety of MK-0616 for Adults with High Cholesterol
SpainEvaluating Once Daily Orforglipron (LY3502970) Compared to Insulin Glargine in Adults with Type 2 Diabetes and Obesity or Overweight who Have Increased Cardiovascular Risk
SpainStudy of Retatrutide for Patients with Type 2 Diabetes and Obesity or Overweight
SpainStudy on the Effects of Retatrutide for Patients with Severe Obesity and Cardiovascular Disease
SpainThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on type 2 diabetes mellitus and obesity management, evaluating new therapeutic approaches for weight reduction and blood sugar control.
Multiple trials are investigating combination therapies with lifestyle modifications for optimal patient outcomes.
Comprehensive studies addressing atherosclerotic cardiovascular disease and hypercholesterolemia, testing new treatments for reducing major adverse cardiovascular events.
Research focuses on both primary prevention and management of established cardiovascular conditions.
Advanced research in multiple sclerosis treatment, including studies of new therapies and comparative analyses of existing treatments for relapsing-remitting forms.
Trials aim to improve treatment efficacy and patient quality of life.
Investigating treatments for chronic kidney disease, particularly in conjunction with diabetes and hypertension, evaluating novel therapeutic combinations.
Focus on slowing disease progression and improving outcomes in complex renal conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
